by James Edward Katz, M.D. | Dec 29, 2022 | COVID-19, Infectious Disease, Medications, Pandemic, Patient Care, SARS-CoV-2
5 reasons why PAXLOVID got a bad rap Summary: It works against all known strains of COVID-19. It reduces the incidence of Long Covid. The components have been used safely for years, and the medication interactions are manageable. Paxlovid should be started within the...
by James Edward Katz, M.D. | Dec 22, 2021 | Activism, COVID-19, Disease, Infectious Disease, Pandemic, Patient Care, Policy, Preventative Medicine, Preventive, Public Health, SARS-CoV-2, Seasonal
Main Image credit: Sumanley xulx from Pixabay Dear John, It has been three weeks since the first report of the omicron variant. The newspapers are filled with headlines with contradictory information. If you feel confused, you are not alone. What should one do about...
by James Edward Katz, M.D. | Oct 30, 2021 | Cancer, Patient Care, Public Health
Why is it Not in Common Use? Cancer cells are hypermetabolic. They manufacture cholesterol at elevated rates to build new cell walls which enables their uncontrolled growth. In cell cultures, tumors deprived of cholesterol stop growing. Pravachol (pravastatin),...
by James Edward Katz, M.D. | Mar 7, 2021 | COVID-19, Pandemic, Patient Care, Preventative Medicine, Public Health, SARS-CoV-2
By Dr. James Katz, MD, MPH A very pleasant bubbe (grandmother) came to the Moderna vaccination clinic in Newton for her first of two shots. She was concerned side effects from her second dose of the Moderna vaccine, scheduled for March 25, might interfere with her...
by James Edward Katz, M.D. | Oct 6, 2020 | Aging, Cardiac health, Cholesterol, Circulatory System, COVID-19, Heart Health, Patient Care, Preventative Medicine, Preventive, Public Health, SARS-CoV-2
Statins Prevent Coronavirus Infection Complications The statin drugs, such as Lipitor, Crestor, etc. reduce the severity of SARS-COV-2 (coronavirus) infections. In three separate studies, one in Malaysia and two at the University of California at San Diego, early...
by James Edward Katz, M.D. | Sep 12, 2020 | COVID-19, Disease, Flu, Infectious Disease, Pandemic, Patient Care, Public Health, SARS-CoV-2
Image by Gerd Altmann from Pixabay Justice Department Approves Pharmaceutical Monopoly to Manufacture Anti-COVID Antibodies James Katz MD The COVID-19 related collapse of the hospitals in Queens, New York, is burnt into the minds of Americans. Who would be the next...
by James Edward Katz, M.D. | Aug 2, 2020 | COVID-19, Events, Infectious Disease, Medications, Pandemic, Patient Care, Policy, Public Health, SARS-CoV-2
In April, I wrote an essay 21st Century Medicine Attacks COVID-19 at Lightspeed, describing how the full weight of modern biotechnology is be brought to bear on this pandemic. In less than 60 days, the COVID-19 spike protein had been identified as the best vaccine...
by James Edward Katz, M.D. | Apr 22, 2020 | COVID-19, Disease, Infectious Disease, Pandemic, Patient Care, Policy, Public Health
I remember the astonishing diversity of life in a drop of lake water I first viewed under a microscope sixty years ago. Now we use cryogenic electron microscopes, DNA sequencers, protein splicers, and supercomputers to create computer simulations of life down to...
by James Edward Katz, M.D. | Apr 2, 2020 | COVID-19, Flu, Infectious Disease, Pandemic, Patient Care, Policy, Preventative Medicine, Preventive, Public Health, SARS-CoV-2, Testing
George Fu Gao, head of the Chinese Center for Disease Control and Prevention, was recently interviewed by Science magazine. Dr. Gao was educated at Oxford and Harvard. He rarely speaks publicly. He is one of the few scientists to have access to the actual Chinese...
by James Edward Katz, M.D. | Mar 1, 2020 | Medicaid, Medicare, Obamacare, Patient Care, Policy, Public Health
After four decades of working under Medicare, I am obligated to explain that “Medicare for All” won’t work as proposed. Myth No. 1 – “Medicare for All” will save money. Medicare’s stated administrative expense is 1.1% which is an accounting mirage. Medicare receives...
by James Edward Katz, M.D. | Nov 23, 2019 | Insurance, Medicaid, Medicare, Obamacare, Patient Care, Policy, Public Health
Part One of Two For many, “Medicare for All” (or Single Payor) is a moral imperative. I, too, am in favor of a population-based payor scheme, but like most doctors, I can see Medicare for All will make the problem worse. The degeneration of Medicare, as seen in my...
by James Edward Katz, M.D. | Jan 31, 2018 | Alzheimer's, Circulatory System, Dementia, Heart Health, Hypertension, Medications, Patient Care, Preventative Medicine, Public Health, Sleep
There is a Way to Fix the Hypertension Crisis. New Guidelines Won’t Do It. In a famous psychology experiment, subjects watch a video of students, moving in circles, pass two basketballs around. The task is to count the number of passes that are made. At the end...